XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
GOODWILL AND OTHER INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill

The changes in the carrying amounts in Goodwill were as follows:
Dollars in millions
Balance at December 31, 2023$21,169 
Acquisitions (Note 4)
580 
Currency translation and other adjustments(11)
Balance at March 31, 2024
$21,738 

Other Intangible Assets

Other intangible assets consisted of the following:

Estimated
Useful Lives
March 31, 2024December 31, 2023
Dollars in millions
Gross carrying amountsAccumulated amortizationOther intangible assets, net Gross carrying amountsAccumulated amortizationOther intangible assets, net
R&D technology(a)
6 years
$1,980 $(28)$1,952 $— $— $— 
Acquired marketed product rights(a)
3 – 15 years
63,871 (42,514)21,357 63,076 (40,184)22,892 
Capitalized software
3 – 10 years
1,545 (1,059)486 1,497 (1,027)470 
IPRD(a)
8,965 — 8,965 3,710 — 3,710 
Total$76,361 $(43,601)$32,760 $68,283 $(41,211)$27,072 
(a)    Includes assets acquired in connection with Mirati and RayzeBio acquisitions, as further described in "—Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements."

Amortization expense of Other intangible assets was $2.4 billion and $2.3 billion during the three months ended March 31, 2024 and 2023, respectively.
An IPRD impairment charge of $20 million was included in Research and development expenses during the three months ended March 31, 2023.